Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ExoPTEN
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Preclinical
Sponsor : NurExone Biologic
Deal Size : Undisclosed
Deal Type : Agreement
NurExone Signs Preclinical Testing Agreement for ExoPTEN Therapy
Details : Vivox will provide CRO services to NurExone to commence human trials, moving towards IND filing in the U.S. for ExoPTEN exosome-based therapy in spinal cord injury treatment.
Brand Name : ExoPTEN
Molecule Type : Large molecule
Upfront Cash : Undisclosed
March 22, 2024
Lead Product(s) : ExoPTEN
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Preclinical
Sponsor : NurExone Biologic
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?